Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す 金 - 無料

Home
MM Activ Sci-Tech Communication
BioSpectrum Asia
BioSpectrum Asia Nov 2024
Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$NaN
 
$NaN/年

お急ぎください、期間限定オファー！

0

営業時間

0

分

0

秒

.

BioSpectrum Asia - BioSpectrum Asia Nov 2024

filled-star
Filter issues ✕
From Choose Date
To Choose Date
BioSpectrum Asia

Magzter GOLDで無制限に

読む BioSpectrum Asia 10,000以上の雑誌や新聞を1回の定期購読で購読できます  

カタログを見る

1ヶ月

$14.99

1年 $149.99

$74.99

$6/month

Save 50%
Hurry, Offer Ends in 1 Days

Hurry! Offer ends in

  • 15 Hours
    • :
  • 51 Mins
    • :
  • 57 Secs
(OR)

BioSpectrum Asiaのみを購読する

この号を購入: BioSpectrum Asia Nov 2024

BioSpectrum Asia Nov 2024 から始まる undefined 号

BioSpectrum Asia Nov 2024 から始まる 12 号

この号を購入する

$0.99

1年

$10.99

Please choose your subscription plan

贈り物 BioSpectrum Asia

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

APAC Bullish on Biosupplier Revenue
Amidst Global Uncertainty The Asia-Pacific (APAC) market plays a
crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues. Between 2021 and 2023, the bioprocessing market was one of the strongest performers, growing at about 18 per cent annually due to COVID-19-driven demand. However,2023 was a challenging year for biosuppliers, with the decline in COVID-19-related spending and various global events impacting business, resulting in plummeting revenue for most firms.
While the bioprocessing sector saw impressive growth between 2021 and 2022, post-COVID-19 normalisation and rising financing costs have led to flat growth from 2022 to 2023. Despite this, the market is expected to rebound over the next two years, with an average growth forecast of around 9 per cent from 2023 to 2027, according to a report from Clearstate.

New Zealand introduces new Mental Health Bill

The Health Ministry in New Zealand has announced that a new Mental Health Bill has been introduced and is now publicly available.

New Zealand introduces new Mental Health Bill0

1 mins

Greater Bay Area International Clinical Trial Institute in Hong Kong to initiate full operations in 2024

The Health Bureau (HHB), Hong Kong government, has announced that after months of preparation with full effort since the Chief Executive put forward in the Policy

Greater Bay Area International Clinical Trial Institute in Hong Kong to initiate full operations in 20241

1 mins

Singapore seizes opportunity to transform healthcare through technology

In response to the convergence of three major developments, namely genomics, artificial intelligence (AI) and the focus on preventive care, the Ministry of Health (MOH) in Singapore is seizing the opportunity to transform healthcare through technology.

Singapore seizes opportunity to transform healthcare through technology2

1 mins

India's CDSCO becomes Affiliate Member of International Medical Device Regulators Forum

To achieve global alignment in its medical device regulatory system, enhance the competitiveness of the domestic industry, and boost transnational prominence, the Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, government of India, applied for Affiliate Membership in the International Medical Device Regulators Forum (IMDRF) in 2024.

India's CDSCO becomes Affiliate Member of International Medical Device Regulators Forum3

1 mins

Japan's Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia

UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and licence agreement for AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development for patients with frontotemporal dementia with progranulin mutations (FTD-GRN).

Japan's Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia4

1 mins

China's CanSino receives over $17 M to accelerate polio vaccine development

China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to propel its recombinant poliovirus vaccine (VLP-Polio) project forward.

China's CanSino receives over $17 M to accelerate polio vaccine development5

1 mins

Caliway Biopharma raises $206 M in Taiwan's biotech largest IPO

Caliway Biopharmaceuticals has announced the successful completion of its initial public offering (IPO) and up-listing from the Emerging Stock Market to the Taipei Exchange.

Caliway Biopharma raises $206 M in Taiwan's biotech largest IPO6

1 mins

SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology

South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, based in the US, by investing $3 million.

SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology7

1 mins

Cytiva opens first Innovation Hub in Korea

Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.

Cytiva opens first Innovation Hub in Korea8

1 mins

Sanyou Bio opens new 10,000-sqm R&D facility in Shanghai

Sanyou Bio recently announced a move into its new 10,000-square-metre R&D building at Shanghai headquarters.

Sanyou Bio opens new 10,000-sqm R&D facility in Shanghai9

1 mins

Sunway Healthcare Group inks MoU with Medtronic to advance medical care in Malaysia

Sunway Healthcare Group from Malaysia and Medtronic have officially signed a Memorandum of Understanding (MoU), marking a significant milestone in their collaborative journey to advance medical care, and underscoring a shared vision of developing solutions to tackle some of the most pressing healthcare challenges.

Sunway Healthcare Group inks MoU with Medtronic to advance medical care in Malaysia10

1 mins

Taiwan's Pharmosa Biopharm expands collaboration with Liquida

Liquidia Corporation, a US-based biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, and Taiwan-based Pharmosa Biopharm have amended the current exclusive licensing agreement for the development and commercialisation of L606, an inhaled, sustained-release formulation of treprostinil currently being evaluated in a clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Taiwan's Pharmosa Biopharm expands collaboration with Liquida11

1 mins

India-Australia partnership to build bio innovation corridor

La Trobe University, Australia and India's Biotechnology Industry Research Assistance Council (BIRAC) have signed a Letter of Intent (LOI) to establish a Bio Innovation Corridor to support the development of research and innovation.

India-Australia partnership to build bio innovation corridor12

1 mins

Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technology Agency (JST) OPERA QISS programme, has raised a total of ¥1.02 billion through a Series B funding round.

Alpha Fusion accelerates astatine-based drug discovery with Series B funding13

1 mins

Mediwhale secures $12 M to enhance cardiovascular and metabolic disease management

Mediwhale, an artificial intelligence (AI)-powered health diagnostics startup based in South Korea, has announced $12 million series A2 investment.

Mediwhale secures $12 M to enhance cardiovascular and metabolic disease management14

1 mins

Singapore launches accelerator programme for startups in digital health innovation

The National University of Singapore (NUS) Medicine Digital Advanced Technology Accelerator (DATA) has launched its Digital Accelerator Programme for startups in the field of digital health innovation.

Singapore launches accelerator programme for startups in digital health innovation15

1 mins

WHO and multilateral development banks kick off $1.5 B primary health financing platform

Execution is starting under the new Health Impact Investment Platform on the first country health investment plans turning original commitment into operational reality.

WHO and multilateral development banks kick off $1.5 B primary health financing platform16

1 mins

WHO adds HPV vaccine for single-dose use

The World Health Organisation (WHO) has announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin (developed by Xiamen Innovax Biotech) has been confirmed for use in a single-dose schedule.

WHO adds HPV vaccine for single-dose use17

1 mins

APAC Bullish on Biosupplier Revenue by Jan Amidst Global Uncertainty

The Asia-Pacific (APAC) market plays a crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues.

APAC Bullish on Biosupplier Revenue by Jan Amidst Global Uncertainty18

10+ mins

Digital Innovations in Diabetes Care

Diabetes affects 537 million people globally and is a major contributor to the non-communicable disease NCD) epidemic. Technological tools such as continuous glucose monitors CGMs) and mobile apps are redefining diabetes management. On this World Diabetes Day November 14, 2024), we explore how digital health is transforming diabetes care and the challenges associated with its integration into healthcare systems.

Digital Innovations in Diabetes Care19

5 mins

Targeted Transformation of Diabetes Care in India

According to the International Diabetes Federation (IDF) about 63 per cent of people with diabetes say that the fear of developing diabetes-related complications affects their well-being.

Targeted Transformation of Diabetes Care in India20

5 mins

"To achieve our 'Skilled India' vision, we'll train a large number of individuals quickly and to high standards"

Jayant Singh Chaudhary, Union Minister of State (Independent Charge), Skill Development and Entrepreneurship, Government of India, in an interaction with BioSpecturm in Hyderabad, shares his insights on the various initiatives taken up by the Centre for skill development programmes, boosting self-employment.

"To achieve our 'Skilled India' vision, we'll train a large number of individuals quickly and to high standards"21

5 mins

"Moving forward, cancer may not be a death threat but a manageable disease with strong control"

Cartherics Pty Ltd, a Melbourne-based biotechnology company led by renowned stem cell biologist and IVF pioneer Prof Alan Trounson, is , focusing on a portfolio of CAR-T and CAR-NK cell products.

"Moving forward, cancer may not be a death threat but a manageable disease with strong control"22

4 mins

"Australia is a great place to do business as we have a superb research community, great partners and very experienced clinical trial units"

Noxopharm Limited, an Australian biotech company, is making strides in the fight against cancer and inflammation with its innovative technology platforms, Chroma and Sofra.

"Australia is a great place to do business as we have a superb research community, great partners and very experienced clinical trial units"23

5 mins

"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"

The University of Sydney Vietnam Institute, officially launched in June 2024, aims to enhance Vietnam’s scientific capacity and contribute to the country’s economic and social development.

"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"24

5 mins

Managing Delicate Role of Donors for Drug Development and Research

A sustainable, active, and diverse donor pool is more important than ever as the frontiers of medical research continue to push the envelope.

Managing Delicate Role of Donors for Drug Development and Research25

5 mins

University of Hong Kong to establish Global Innovation Centre

To consolidate Hong Kong's leading position in basic research, the University of Hong Kong (HKU) is planning to establish the Global Innovation Centre (GIC), an upstream technology research facility, in Pokfulam.

University of Hong Kong to establish Global Innovation Centre26

1 mins

National University of Singapore and Imperial College London establish major research partnership

National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen research collaborations.

National University of Singapore and Imperial College London establish major research partnership27

1 mins

Victor Ambros and Gary Ruvkun win 2024 Nobel Prize in Physiology or Medicine for discovery of microRNA

The Nobel Assembly at Karolinska Institutet has decided to award the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Victor Ambros and Gary Ruvkun win 2024 Nobel Prize in Physiology or Medicine for discovery of microRNA28

1 mins

Nobel Prize in Chemistry 2024 to trio for cracking code for protein structures

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024, with one half to David Baker, University of Washington, US for computational protein design; and the other half jointly to Demis Hassabis, Google DeepMind, London, UK; and John M. Jumper, Google DeepMind, London, UK for protein structure prediction.

Nobel Prize in Chemistry 2024 to trio for cracking code for protein structures29

1 mins

Dr Makoto Sugita steps in as President of Nxera Pharma Japan

Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

Dr Makoto Sugita steps in as President of Nxera Pharma Japan30

1 mins

Integris appoints medtech veteran Probir Das as new CEO

Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.

Integris appoints medtech veteran Probir Das as new CEO31

1 mins

Clarity Pharma promotes Michelle Parker to CEO

Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.

Clarity Pharma promotes Michelle Parker to CEO32

1 mins

Spider venom heart drug moves to clinical trials in Australia

A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).

Spider venom heart drug moves to clinical trials in Australia33

1 mins

India develops portable ultrasound scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.

India develops portable ultrasound scanner for sports injury diagnosis34

1 mins

Singapore designs novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.

Singapore designs novel gene therapy offering hope for epilepsy patients35

1 mins

Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine

Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.

Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine36

1 mins

Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis

US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.

Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis37

1 mins

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers38

1 mins

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time39

1 mins

すべてのストーリーを読む BioSpectrum Asia

BioSpectrum Asia Description:

出版社: MM-Activ-Sci-Tech-Communication

カテゴリ: Business

言語: English

頻度: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

最近の問題

関連タイトル

人気カテゴリー

すべて表示